Outcomes Among hypertensive patients with concomitant peripheral and coronary artery disease: findings from the INternational VErapamil-SR/Trandolapril STudy. - Test2 - elhamkhani - TriplyDB

Outcomes Among hypertensive patients with concomitant peripheral and coronary artery disease: findings from the INternational VErapamil-SR/Trandolapril STudy.

Outcomes Among hypertensive patients with concomitant peripheral and coronary artery disease: findings from the INternational VErapamil-SR/Trandolapril STudy.

http://www.wikidata.org/entity/Q34396234

about

Treatment of hypertension in peripheral arterial disease Effect of blood pressure lowering medications on leg ischemia in peripheral artery disease patients: A meta-analysis of randomised controlled trials Tight blood pressure control and cardiovascular outcomes among hypertensive patients with diabetes and coronary artery disease.Characteristics and long-term follow-up of participants with peripheral arterial disease during ALLHAT.Mortality implications of angina and blood pressure in hypertensive patients with coronary artery disease: New data from extended follow-up of the International Verapamil/Trandolapril Study (INVEST)Effectiveness of olmesartan-based treatment on home and clinic blood pressure in elderly patients with masked and white coat hypertension.The effects of comorbidity on the benefits and harms of treatment for chronic disease: a systematic review.Simple integer risk score to determine prognosis of patients with hypertension and chronic stable coronary artery disease.β-Blockers in coronary artery disease management.Peripheral arterial disease--what do we need to know?Tight blood pressure control in diabetes: evidence-based review of treatment targets in patients with diabetes.Prevention of coronary artery disease: recent advances in the management of hypertension.2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.Antihypertensive treatment and blood pressure in diabetic and nondiabetic patients: the lower, the better?Treatment of hypertension: lower is better, or is it?Renal denervation for mild-moderate treatment-resistant hypertension : A timely intervention?Too much blood pressure?J Curve in Hypertension.The Evolving Treatment of Peripheral Arterial Disease through Guideline-Directed Recommendations.2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS)

P2860

Q24201969-3F545922-13A3-4C63-9470-4257ECFCEBFF Q33757625-FEC27465-B399-4B1B-A455-2EBA1003FA12 Q34432935-53C74465-C720-47F4-9574-E6273F1DA0D2 Q34546377-3AC17416-4B92-46DF-BCA6-FA3AF85F1C2C Q34747258-A9FEEE68-89F2-4E3A-93B9-75C4CC4A8DC2 Q35152926-D9BAF48A-1D15-4DCB-8C66-18CC1084450A Q35427801-7D488C58-282D-4213-9B90-D119A2D9B685 Q37310382-4EA5CF91-497D-43C5-A34F-23E2CE73CAA4 Q37839729-BC813AB8-1D52-4F87-824D-C56F79F7D250 Q37896022-1BE08EAE-D815-4FA2-9815-95740F77BF4B Q37964515-082A7C1D-E276-4F8F-A98A-B3EED1F849B5 Q38075808-E515228D-B9E4-4E0B-BF8C-F05C94E5288F Q39007230-A8B66313-8D7B-48A3-A9F1-C12C34BB8039 Q39007236-75AC2F1E-1E27-465D-94B0-17DB019D7F28 Q39988729-80200495-5F06-4E68-871A-B70B61C06625 Q42878857-9E9F58E2-BEA1-49C7-B330-9F23F2693EBC Q47285309-7A83C3B7-C5F2-4B57-A61B-8B44FB7B134E Q47626173-1A2100EB-8A28-4BCD-8FFC-5837B11471BD Q49245728-A9B9C489-6B09-4484-AFF1-E82788CD7145 Q49308634-B9C1F6E9-A664-4B26-B28C-55049901821A Q57621177-52A9DE37-D9F2-4712-879A-5EE7C149512B

P2860

Outcomes Among hypertensive patients with concomitant peripheral and coronary artery disease: findings from the INternational VErapamil-SR/Trandolapril STudy.

http://www.wikidata.org/entity/Q34396234

description

2009 nî lūn-bûn

@nan

2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Outcomes Among hypertensive pa ...... rapamil-SR/Trandolapril STudy.

@ast

Outcomes Among hypertensive pa ...... rapamil-SR/Trandolapril STudy.

@en

Outcomes Among hypertensive pa ...... rapamil-SR/Trandolapril STudy.

@nl

type

label

Outcomes Among hypertensive pa ...... rapamil-SR/Trandolapril STudy.

@ast

Outcomes Among hypertensive pa ...... rapamil-SR/Trandolapril STudy.

@en

Outcomes Among hypertensive pa ...... rapamil-SR/Trandolapril STudy.

@nl

prefLabel

Outcomes Among hypertensive pa ...... rapamil-SR/Trandolapril STudy.

@ast

Outcomes Among hypertensive pa ...... rapamil-SR/Trandolapril STudy.

@en

Outcomes Among hypertensive pa ...... rapamil-SR/Trandolapril STudy.

@nl

P1433

Q34396234-016D977C-0856-4E90-987F-13A290D8F1B7

P1476

Q34396234-1378BCC6-74CC-42F8-9B91-436F87BF3EB1

P2093

Q34396234-24032E89-6107-4324-B846-92601938B9F4

Q34396234-36440416-27BA-453F-9C38-45493742F803

Q34396234-575B438D-A584-4A80-B918-33A51B652EC4

Q34396234-8F34A468-325B-448E-800F-D406B211C858

Q34396234-C368CFA1-3455-4383-9715-F527FFE79994

Q34396234-D915034F-7062-4E3F-99D2-7474E1C698B2

Q34396234-DC0E4E81-9072-421E-98BA-E343348EC412

P2860

Q34396234-01ADA01E-3FEA-4450-878B-BDE44BB7F97D

Q34396234-036CC4A9-7659-409A-A906-1CEF8CF541BF

Q34396234-096C9AC9-2C1F-46FF-8771-4D3AB188CE69

Q34396234-0E102BF2-44E1-445A-8170-2A60EA2872D1

Q34396234-15566A8D-8EFF-41D6-98D0-930002AB9187

Q34396234-1CDC6786-0498-4790-8D9D-6E55D9941C14

Q34396234-211419D3-1CF7-471C-B7BA-7968576012E0

Q34396234-22D751F9-0E9F-48AB-B3D4-28A2F865E265

Q34396234-293F8DBF-FADE-4C32-B770-C96BA13039E5

Q34396234-2BDD736F-7E63-4117-B36C-DCAF966D416D

P304

Q34396234-58F8D9DF-8FEF-46E7-8330-02412FDB7A12

P31

Q34396234-B9C29D19-1A2C-4CF1-85E5-2A6AD13A9163

P356

Q34396234-54F118C5-6D52-417D-B099-C3D57B1A791E

P407

Q34396234-2A569AE3-0305-49E6-8AFF-C696849281FF

P433

Q34396234-234BAD6A-22B8-4E45-8432-58AAC08D0F52

P478

Q34396234-D4CB56E4-2DAB-4F38-AEBE-DEE50EF074E9

P577

Q34396234-38A06C12-1585-49CD-8FB6-F90BAAF68023

P698

Q34396234-ACD680F4-5123-48A9-936F-81251D05558F

P932

Q34396234-88BDAE4F-5A27-4978-A762-124021448636

P356

HYPERTENSIONAHA.109.142240

P1433

P1476

Outcomes Among hypertensive pa ...... rapamil-SR/Trandolapril STudy.

@en

P2093

Anthony A Bavry

http://www.w3.org/2001/XMLSchema#string

Carl J Pepine

http://www.w3.org/2001/XMLSchema#string

Eileen M Handberg

http://www.w3.org/2001/XMLSchema#string

R David Anderson

http://www.w3.org/2001/XMLSchema#string

Rhonda M Cooper-Dehoff

http://www.w3.org/2001/XMLSchema#string

Scott J Denardo

http://www.w3.org/2001/XMLSchema#string

Yan Gong

http://www.w3.org/2001/XMLSchema#string

P2860

Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

Treatment of hypertension in the prevention and management of ischemic heart disease: a scientific statement from the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Pr

Use of ankle brachial pressure index to predict cardiovascular events and death: a cohort study

Beta blockers for peripheral arterial disease.

Impact of ramipril in patients with evidence of clinical or subclinical peripheral arterial disease.

Comparison of the effects of antihypertensive agents on central blood pressure and arterial stiffness in isolated systolic hypertension.

The Minnesota Regional Peripheral Arterial Disease Screening Program: toward a definition of community standards of care.

Medication underuse during long-term follow-up in patients with peripheral arterial disease.

P304

48-53

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/HYPERTENSIONAHA.109.142240

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

55

http://www.w3.org/2001/XMLSchema#string

P577

2009-12-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19996066

http://www.w3.org/2001/XMLSchema#string

P932

3000120

http://www.w3.org/2001/XMLSchema#string